2025 PRESENTING COMPANIES
WEDNESDAY, MARCH 19, 2025 | AUSTIN CONVENTION CENTER
2025 PRESENTING COMPANIES
WEDNESDAY, MARCH 19, 2025 | AUSTIN CONVENTION CENTER
Drew Taylor, PhD, CEO - Acorn Biolabs
With offices in Toronto, Canada and Los Angeles, U.S., Acorn Biolabs is a next-generation personalized regenerative medicine company with services currently offered at partner clinic locations across North America. Acorn has developed the world’s first non-invasive, follicle-based cell cryopreservation service and has patented cell-based treatments made from a patient’s own hair follicle cells. Learn more at www.acorn.me
MaryAnn Guerra, CEO - Aesthetics Biomedical
Aesthetics Biomedical®, Inc., headquartered in Phoenix, AZ, is committed to the development and distribution of novel aesthetic devices, products, and services in the global market. Aesthetics Biomedical’s innovation center is a leader in breakthrough technologies and combination therapies for its clients, physician network and the aesthetic arena, creating novel patient treatment experiences that benefit from ongoing research, approved clinical indications for use, as well as a personalized approach designed for consumer benefit.
Charlie Goodwin, CEO - Apyx Medical
Apyx Medical is a leading advanced energy technology company dedicated to revolutionizing surgical aesthetics and body contouring. With a passion for elevating lives, Apyx Medical develops and markets cutting-edge products powered by its proprietary Helium Plasma Platform Technology, including Renuvion®, the #1 trusted body contouring technology by surgeons, and J-Plasma®, designed for hospital surgical applications. Renuvion is redefining body contouring by giving surgeons a powerful, precise, and minimally invasive way to achieve superior skin contraction and sculpting results. Backed by more than 90 clinical studies, Renuvion has become the go-to solution for both surgeons and patients seeking exceptional aesthetic outcomes. As the leader in advanced body contouring solutions, Apyx Medical is committed to innovation, clinical excellence, and empowering surgeons to deliver life-changing results.
Amanda Kraus, Head of Marketing - Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more.
With our own research and development team focused on driving innovation in aesthetics, we’re committed to providing the most comprehensive science-based product offerings available.
Bradford Conlon, CEO - Bimini Healthtech
Bimini Health Tech provides targeted bio-therapeutic solutions in plastic surgery and regenerative medicine. Since 2013, Bimini has developed, acquired, and commercialized innovative products that offer patients and physicians premium care options. The Bimini Health Tech portfolio includes the brands Healeon®, Kerastem®, Dermapose®, Puregraft® Fat Transfer, Puregraft® Essence ADM, and now the Serene Breast Implant.
Taylor Harris, CEO - Cutera
Brisbane, California-based Cutera, Inc. is a leading provider of aesthetic and dermatology solutions for practitioners globally. For over 25 years, Cutera continues to improve lives through medical aesthetic technologies that are driven by science and powered through partnerships. For more information, call 1-888-4-CUTERA or visit Cutera.com.
Louis Bucky, MD, FACS, Founding Investor & Board Member
Cypris Medical is a pioneering medical technology company focused on developing innovative, minimally invasive solutions for aesthetic and reconstructive procedures. The company's flagship technology, the Xact™ device, offers a revolutionary approach to soft tissue fixation and elevation, providing patients with natural-looking results without the need for traditional surgical techniques. By combining advanced engineering with clinical insights, Cypris Medical aims to transform aesthetic practices, delivering effective and safe outcomes that enhance patient satisfaction and streamline procedural efficiency.
Jon Edelson, MD, Chairman, CEO & President - Eirion Therapeutics
Eirion Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative therapies in aesthetic medicine and dermatology. Eirion leverages cutting-edge science and advanced delivery technologies to create novel, minimally invasive treatments that address unmet needs in aesthetic and therapeutic skin care. With a robust pipeline of proprietary products, the company is focused on delivering safe, effective, and long-lasting solutions that enhance patient outcomes and transform clinical practice.
Murray Jensen, Managing Director; Director of Clinical and Scientific Affairs
Decades of Innovating Medical Aesthetics Research
Your leading partner for conducting ethical, high-quality clinical trials.
Choosing ethica CRO empowers organizations to navigate regulations, streamline development, and excel in medical aesthetics product commercialization.
ethica's expertise spans the full spectrum of aesthetic medicine, ensuring that new treatments not only meet the highest standards of quality but also address the diverse needs of patients seeking aesthetic enhancements.
Carlos Reis Pinto, CEO - GC Aesthetics
GC Aesthetics is a leading global medical device company specializing in high-quality breast implants and aesthetic solutions. With over 40 years of expertise, the company has developed a strong reputation for innovation, safety, and patient satisfaction in breast augmentation and reconstruction. GC Aesthetics offers a diverse portfolio of implants, including advanced silicone gel implants designed for natural aesthetics, durability, and biocompatibility. Committed to empowering both patients and surgeons, the company provides comprehensive educational resources and cutting-edge technologies to enhance surgical outcomes. With a presence in over 70 countries, GC Aesthetics continues to shape the future of aesthetic medicine through innovation, science, and patient-focused solutions.
Paul Herchman, CEO - GetHairMD
GetHairMD is a leading provider of advanced hair restoration solutions, offering a comprehensive range of treatments designed to address hair loss in both men and women. Utilizing the latest medical and aesthetic technologies, GetHairMD provides non-surgical and surgical options, including regenerative therapies, laser treatments, medications, and hair transplant procedures. Their team of expert physicians and specialists customizes treatment plans to suit each patient's unique needs, ensuring natural-looking results and long-term hair health. Committed to innovation and patient satisfaction, GetHairMD is at the forefront of the hair restoration industry, helping individuals regain confidence through effective, science-backed solutions.
Erik Haines, Managing Director - Guidepoint Qsight
Built on a foundation of proprietary healthcare data, Guidepoint Qsight is dedicated to providing unparalleled data and analytics solutions that empower businesses in the Aesthetics and Medical Technology industries to make strategic, data-driven decisions. By combining comprehensive market intelligence with innovative technology, Qsight delivers reliable and consistent industry insights that enable companies to optimize their sales and marketing strategies, proactively prepare for and respond to ever-evolving market dynamics and achieve their business goals.
Carrie Caulkins, Chief Marketing Officer - Hydrafacial
Hydrafacial is a globally recognized leader in skin health, offering an innovative, non-invasive treatment that combines cleansing, exfoliation, extraction, hydration, and antioxidant protection in one seamless experience. Using its patented Vortex-Fusion® technology, Hydrafacial deeply cleanses and nourishes the skin, delivering instant and long-lasting results for all skin types. Trusted by dermatologists, aestheticians, and skincare professionals worldwide, Hydrafacial has revolutionized the beauty and aesthetics industry with its customizable, multi-step approach to improving skin tone, texture, and overall radiance. With a commitment to personalization and skincare innovation, Hydrafacial empowers individuals to achieve their healthiest, most glowing skin.
Laura Ellis, MD, Founder - LevEllis
LevEllis is revolutionizing skin care. We are dedicated to redefining skincare by delivering a novel and disruptive product line containing factors from proprietary laboratory generated cells registered with the NIH, validated with published, scientifically proven results.
We will help patients extend the health span of their skin and achieve the confidence and vitality that can only be reached with an active, highly effective biologic solution.
Kevin Colbert, Business Development, co-founder - LifeSprout
LifeSprout is a biotechnology company pioneering the next generation of regenerative aesthetics and soft tissue restoration solutions. Utilizing its proprietary Regenerative Matrix Technology, LifeSprout develops cutting-edge biomimetic materials designed to enhance tissue regeneration, providing natural, long-lasting results for aesthetic and reconstructive applications. The company's innovative platform merges the benefits of biocompatible scaffolds with advanced bioengineering to restore volume loss and improve patient outcomes in facial aesthetics, body contouring, and soft tissue repair. With a focus on safety, efficacy, and minimally invasive solutions, LifeSprout is redefining the future of regenerative aesthetics and soft tissue therapeutics.
Sean Shapiro, CCO - MedShift
MedShift, a medical technology company founded in 2015 and headquartered in Charlotte, NC, is an emerging leader in the healthcare industry. MedShift is one of the largest and fastest growing solution providers to the aesthetic industry and is differentiated by its technology and software as a service focus. The company brings opportunities to drive growth and scale to medical device manufacturers as well as individual medical providers across various markets, including Dermatology, Gynecology, Plastic Surgery, and MedSpa. MedShift's business is centered around four business lines, Specialty Device Subscription Financing, Pulse Connected Product (an IoT product offering), Velocity Technology Suite (Enterprise Software as a Service), and the MedShift Store, an online marketplace featuring a range of complementary products and services that streamline the complex supply-and-demand landscape of
device consumables and injectables. MedShift's mission is to drive business transformation and power sales through the use of modern technology. The company currently has partnered with over 25 aesthetic manufacturers and distributors, a portfolio of 113 devices, and over 2,300 customers.
Alec McCarthy, PhD, Global Medical Director for Regenerative Aesthetics - Merz Aesthetics
We have been family-owned since 1908 and treat customers, patients and employees like family. It drives our unique connection with health care professionals, and it’s what makes their success our success. For us it’s personal — listening, advising, supporting and celebrating them as we pursue a shared vision to help the world look better, feel better and live better.
We are a leading, global aesthetics business, and our award-winning portfolio of injectables, devices and skin care products help health care professionals fuel confidence through aesthetic medicine.
Steven Cohen, MD, FACS, Founder - Morphiya
Morphiya is a cutting-edge technology company revolutionizing the field of aesthetic medicine through advanced AI-driven solutions. Specializing in personalized aesthetic simulations, Morphiya empowers both patients and practitioners by providing highly accurate, real-time visualizations of potential treatment outcomes. By integrating artificial intelligence, computer vision, and deep learning, Morphiya enhances patient consultations, improves decision-making, and streamlines the treatment planning process. With a commitment to innovation and precision, Morphiya is reshaping the way aesthetic procedures are approached, ensuring more predictable, natural, and satisfying results for patients and providers alike.
Juan Jose Chacon-Quirós, CEO & Founder - Establishment Labs
More than two decades ago, Motiva® by Establishment Labs® changed the industry paradigm by putting women’s health first. With innovation, safety, and technology, we started a revolution in the Femtech sphere by creating a new space that cared for women’s unmet needs within the breast aesthetic and reconstruction fields. The main goal: to create Femtech solutions that heal, normalize, and democratize breast health and aesthetics.
James Hartman, President & CEO - Ourself
Ourself is a science-first, evidence-based skincare company, created by the founders of SkinMedicaTM and Alastin SkincareTM . Leveraging 20 years of biotech and skincare expertise, Ourself developed a scientifically advanced delivery technology that redefines what’s possible in cosmetic skincare.
Qing Yu Christina Weng, MD, CMO - Pelage
Pelage Pharmaceuticals is a pioneering biotechnology company dedicated to advancing hair restoration solutions through cutting-edge pharmaceutical research. Focused on developing novel, non-invasive treatments for hair loss, Pelage leverages the latest advancements in regenerative medicine, molecular biology, and dermatology to create effective therapies targeting the underlying causes of hair thinning and baldness. With a commitment to scientific innovation and clinical excellence, Pelage aims to provide safe, effective, and accessible solutions for individuals seeking to restore hair growth and improve scalp health.
Alon Bloomenfeld, CEO - Raziel Therapeutics
Raziel Therapeutics is a clinical-stage biopharmaceutical company pioneering innovative injectable treatments for aesthetic and metabolic conditions. The company is developing first-in-class, long-lasting therapies targeting subcutaneous fat reduction, offering a novel approach to non-surgical body contouring and fat disorder management. Raziel’s lead product candidate is designed to selectively reduce fat cells through a proprietary mechanism, with potential applications in both aesthetic medicine and medical conditions associated with excess fat accumulation. With a commitment to scientific innovation and patient-centered solutions, Raziel Therapeutics is redefining the landscape of non-invasive fat reduction treatments.
John Oakley, Chief Executive Officer and Director - Revian
Revian is a cutting-edge medical technology company specializing in innovative light-based solutions for hair loss treatment. Utilizing dual-wavelength LED technology, Revian’s non-invasive approach is designed to stimulate natural hair growth and improve scalp health without the need for drugs or surgery. Their flagship product, the Revian Red System, is an FDA-cleared, wearable cap that uses precise wavelengths of light to activate the body’s natural regenerative processes, enhancing blood flow and reducing inflammation to promote healthier, fuller hair. With a strong foundation in scientific research and dermatology, Revian is revolutionizing the field of hair restoration with an effective, drug-free solution for individuals experiencing hair thinning and loss.
Alisa Lask, CEO - Rion Aesthetics
Rion Aesthetics is a regenerative aesthetics company, founded in Rochester, Minnesota, pioneering the use of platelet-derived exosome technology in investigational studies for hair restoration and facial wrinkles. Backed by over 15 years of visionary science, we aim to transform the regenerative aesthetics market to bring beauty from within.
Our passion for aesthetics and core value of helping people achieve their aesthetic goals is reflected in our robust product portfolio and pipeline. We have investigational studies currently underway for hair restoration and facial wrinkles for potential FDA indications.
From this investigational research, we also discovered the benefits of platelet extract on skin health. Through the launch of ( plated )™ Skin Science, we will transform the skincare market using our revolutionary Renewosome™ technology from platelet extract to help rejuvenate the skin.
Andy Balk, Lead Engineer - Sciton
Sciton is committed to delivering high-quality laser and light-based solutions to healthcare professionals who value technological excellence, “made in the USA” quality, and exceptional customer support. Sciton's extensive product range covers a variety of applications, including fractional and full-field skin resurfacing, skin revitalization, phototherapy, vascular treatments, scar reduction, acne treatment, body contouring, hair reduction, and women's health. With a global footprint, Sciton conducts direct sales in the United States, Canada, the United Kingdom, the European Union, Australia, and Japan, while also partnering with distributors in over 45 countries. For further information about Sciton and its product offerings, visit www.sciton.com.
Joseph Brown, PhD, Chief Technology and Operations Officer - Sofregen
Sofregen Medical is an innovative medical technology company specializing in regenerative aesthetics and soft tissue restoration. Utilizing its proprietary Silk Voice® technology, Sofregen offers minimally invasive solutions that harness the natural properties of silk protein to support tissue regeneration and enhance aesthetic outcomes. The company's pioneering approach provides clinicians with advanced tools to restore soft tissue volume, improve vocal fold insufficiency, and achieve natural-looking, long-lasting results. Sofregen is dedicated to advancing the field of regenerative medicine by combining biocompatible materials with clinical expertise to address unmet needs in both aesthetic and therapeutic applications.
Philippe Schaison, PhD, CEO - Soltego
Soltego is a cutting-edge biotechnology company dedicated to advancing photopharmacology and optogenetics to develop innovative, light-activated therapies. Focused on ophthalmology and neuroscience, Soltego harnesses light-sensitive molecules to create targeted, controllable treatments that offer unprecedented precision and reduced side effects. By leveraging novel drug delivery platforms and optically regulated compounds, the company is pioneering next-generation therapeutics for retinal diseases, neurodegenerative conditions, and other unmet medical needs. Soltego's breakthrough approach is poised to revolutionize how diseases are treated at a molecular level, driving forward the future of precision medicine.
Cindy Eckert, CEO - Sprout Pharmaceuticals
Sprout Pharmaceuticals is a pioneering company dedicated to women's health, best known for developing Addyi® (flibanserin), the first and only FDA-approved treatment for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Sprout is committed to advocating for women's sexual health and wellness, offering innovative solutions that address unmet medical needs. The company's mission is to empower women with choices, provide education on HSDD, and break down barriers to meaningful conversations about women's sexual health.
Caro Van Hove, President - Tiger Aesthetics Medical
At Tiger Aesthetics, we are committed to delivering new, cutting-edge products that meet the evolving needs of aesthetic practitioners and their patients. With a focus on three primary clinical areas – reconstruction, cosmetic and regenerative – Tiger Aesthetics enables practitioners to provide life-changing results for a wide range of patients.
Company's Website ( https://tiger-aesthetics.com/ )
Dina Elsherif, CEO - Trufacial
TruFacial is a revolutionary skincare company that combines advanced technology with personalized treatments to deliver next-generation facial rejuvenation. Designed for medical spas, dermatologists, and aesthetic professionals, TruFacial offers customized, high-tech facial solutions that enhance skin health, hydration, and radiance. Utilizing proprietary technology and innovative skincare formulations, TruFacial provides non-invasive, results-driven treatments that cater to individual skin needs. With a focus on efficacy, luxury, and accessibility, TruFacial is redefining the future of professional skincare and aesthetic treatments.
Shlomo Assa - Inventor, Co-Founder & President - Acclaro Medical
UltraClear™ is a leading-edge laser technology company focused on advancing the field of aesthetic dermatology through its revolutionary, FDA-cleared UltraClear™ Laser System. Utilizing a first-of-its-kind cold ablative 3-micron fiber laser, UltraClear™ offers a versatile, customizable, and effective approach to skin rejuvenation with minimal downtime. The company’s technology provides practitioners with a powerful tool to treat a wide range of skin concerns, delivering natural, long-lasting results while prioritizing patient safety and comfort. UltraClear™ is committed to setting new standards in the aesthetics industry by combining innovation with exceptional clinical outcomes.
Domenic Serafino, CEO - Ulvera AI
Ulvera AI is a cutting-edge artificial intelligence company revolutionizing aesthetic and dermatological care through advanced AI-powered skin analysis and diagnostics. By leveraging machine learning and deep learning algorithms, Ulvera AI delivers precise, real-time insights to help clinicians, medical spas, and aesthetic practitioners enhance treatment planning, patient outcomes, and procedural efficiency. Focused on personalized skincare and aesthetic optimization, Ulvera AI is driving the future of data-driven beauty and medical aesthetics, ensuring better accuracy, efficiency, and patient satisfaction in the ever-evolving world of aesthetic medicine.
Vojin Kos, CEO - Vrtly
Vrtly is the first WiFi-enabled marketing platform that gives you complete control of the screens in your aesthetics practice. Simply insert our HDMI vrtStick into your TV and easily manage the screen from your personalized web app. Select the brands you carry and let us refresh their content in real time. Plus, upload your own photos and videos, too. Vrtly is completely free for aesthetic practices thanks to the support and partnership of aesthetic brands.